JP7292258B2 - 縦列反復配列を有するドナーdna修復鋳型を使用する部位特異的なdna改変 - Google Patents

縦列反復配列を有するドナーdna修復鋳型を使用する部位特異的なdna改変 Download PDF

Info

Publication number
JP7292258B2
JP7292258B2 JP2020507491A JP2020507491A JP7292258B2 JP 7292258 B2 JP7292258 B2 JP 7292258B2 JP 2020507491 A JP2020507491 A JP 2020507491A JP 2020507491 A JP2020507491 A JP 2020507491A JP 7292258 B2 JP7292258 B2 JP 7292258B2
Authority
JP
Japan
Prior art keywords
dna
donor
repair template
sequence
rca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020507491A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020517299A5 (https=
JP2020517299A (ja
Inventor
ジョン・リチャード・ネルソン
ロバート・スコット・ダシー
パトリック・マッコイ・スプーナー
ジョン・アンソニー・シール
リサ・アン・ロウリー
アンジャ・ジョシファ・スミス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Life Sciences Solutions USA LLC
Original Assignee
Amersham Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Biosciences Corp filed Critical Amersham Biosciences Corp
Publication of JP2020517299A publication Critical patent/JP2020517299A/ja
Publication of JP2020517299A5 publication Critical patent/JP2020517299A5/ja
Application granted granted Critical
Publication of JP7292258B2 publication Critical patent/JP7292258B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2020507491A 2017-04-19 2018-04-19 縦列反復配列を有するドナーdna修復鋳型を使用する部位特異的なdna改変 Active JP7292258B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/491,125 2017-04-19
US15/491,125 US11834670B2 (en) 2017-04-19 2017-04-19 Site-specific DNA modification using a donor DNA repair template having tandem repeat sequences
PCT/US2018/028366 WO2018195313A1 (en) 2017-04-19 2018-04-19 Site-specific dna modification using a donor dna repair template having tandem repeat sequences

Publications (3)

Publication Number Publication Date
JP2020517299A JP2020517299A (ja) 2020-06-18
JP2020517299A5 JP2020517299A5 (https=) 2021-05-27
JP7292258B2 true JP7292258B2 (ja) 2023-06-16

Family

ID=62196680

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020507491A Active JP7292258B2 (ja) 2017-04-19 2018-04-19 縦列反復配列を有するドナーdna修復鋳型を使用する部位特異的なdna改変

Country Status (6)

Country Link
US (1) US11834670B2 (https=)
EP (1) EP3612630B1 (https=)
JP (1) JP7292258B2 (https=)
CN (1) CN110709514B (https=)
CA (1) CA3062154A1 (https=)
WO (1) WO2018195313A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015330699B2 (en) 2014-10-10 2021-12-02 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
EP4464338A3 (en) 2014-11-07 2025-02-12 Editas Medicine, Inc. Systems for improving crispr/cas-mediated genome-editing
EP3353296B1 (en) 2015-09-24 2020-11-04 Editas Medicine, Inc. Use of exonucleases to improve crispr/cas-mediated genome editing
US11597924B2 (en) 2016-03-25 2023-03-07 Editas Medicine, Inc. Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
US11236313B2 (en) 2016-04-13 2022-02-01 Editas Medicine, Inc. Cas9 fusion molecules, gene editing systems, and methods of use thereof
US11866726B2 (en) 2017-07-14 2024-01-09 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
US10350307B2 (en) * 2017-09-18 2019-07-16 General Electric Company In vivo RNA or protein expression using double-stranded concatemeric DNA including phosphorothioated nucleotides
US20200370070A1 (en) * 2017-11-17 2020-11-26 The Johns Hopkins University Compositions and methods for efficient genome editing
KR20210045360A (ko) 2018-05-16 2021-04-26 신테고 코포레이션 가이드 rna 설계 및 사용을 위한 방법 및 시스템
EP4004198A4 (en) * 2019-07-23 2023-07-19 Pioneer Hi-Bred International, Inc. DONOR DESIGN STRATEGY FOR CRISPR-CAS9 GENOME EDITING

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016500262A (ja) 2012-12-12 2016-01-12 ザ・ブロード・インスティテュート・インコーポレイテッ 遺伝子産物の発現を変更するためのCRISPR−Cas系および方法
US20160046985A1 (en) 2013-03-15 2016-02-18 Complete Genomics, Inc. Multiple tagging of long dna fragments

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648245A (en) * 1995-05-09 1997-07-15 Carnegie Institution Of Washington Method for constructing an oligonucleotide concatamer library by rolling circle replication
US8071332B2 (en) * 2007-08-10 2011-12-06 Toto Ltd. Recombinant mammal cells, method of producing thereof, and method of producing proteins of interest
US8921072B2 (en) 2008-09-02 2014-12-30 General Electric Compnay Methods to generate DNA mini-circles
CN102575264A (zh) * 2009-09-18 2012-07-11 瑟莱克斯公司 增加的转基因表达和加工的产品和方法
US9273324B2 (en) * 2010-12-05 2016-03-01 Andrew S. Belmont Recombinant gene expression
WO2012168307A2 (en) 2011-06-07 2012-12-13 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Improved recombination efficiency by inhibition of nhej dna repair
AU2013266968B2 (en) * 2012-05-25 2017-06-29 Emmanuelle CHARPENTIER Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
PL3360964T3 (pl) 2012-12-06 2020-03-31 Sigma-Aldrich Co. Llc Modyfikacja i regulacja genomu oparta na crispr
EP2840140B2 (en) 2012-12-12 2023-02-22 The Broad Institute, Inc. Crispr-Cas based method for mutation of prokaryotic cells
WO2014194190A1 (en) 2013-05-30 2014-12-04 The Penn State Research Foundation Gene targeting and genetic modification of plants via rna-guided genome editing
EP4194557A1 (en) 2014-08-06 2023-06-14 Institute for Basic Science Genome editing using campylobacter jejuni crispr/cas system-derived rgen
AU2015330699B2 (en) 2014-10-10 2021-12-02 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
EP4464338A3 (en) 2014-11-07 2025-02-12 Editas Medicine, Inc. Systems for improving crispr/cas-mediated genome-editing
CA2981077A1 (en) * 2015-04-03 2016-10-06 Dana-Farber Cancer Institute, Inc. Composition and methods of genome editing of b-cells

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016500262A (ja) 2012-12-12 2016-01-12 ザ・ブロード・インスティテュート・インコーポレイテッ 遺伝子産物の発現を変更するためのCRISPR−Cas系および方法
US20160046985A1 (en) 2013-03-15 2016-02-18 Complete Genomics, Inc. Multiple tagging of long dna fragments

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Cell Reports,2016年,Vol.14,p.2263-2272
Nucleosides, Nucleotides, and Nucleic Acids,2008年,Vol.27,p.224-243

Also Published As

Publication number Publication date
CN110709514A (zh) 2020-01-17
EP3612630B1 (en) 2023-08-30
CN110709514B (zh) 2024-03-08
EP3612630A1 (en) 2020-02-26
US20180305718A1 (en) 2018-10-25
US11834670B2 (en) 2023-12-05
CA3062154A1 (en) 2018-10-25
JP2020517299A (ja) 2020-06-18
WO2018195313A1 (en) 2018-10-25

Similar Documents

Publication Publication Date Title
JP7292258B2 (ja) 縦列反復配列を有するドナーdna修復鋳型を使用する部位特異的なdna改変
US20230091847A1 (en) Compositions and methods for improving homogeneity of dna generated using a crispr/cas9 cleavage system
JP7605852B2 (ja) クラスiiのv型crispr系
CN111373041A (zh) 用于基因组编辑和调节转录的crispr/cas系统和方法
EA038500B1 (ru) Термостабильные нуклеазы cas9
US20200232005A1 (en) Methods of Producing and Using Single-Stranded Deoxyribonucleic Acids and Compositions for Use in Practicing the Same
EP4041884A1 (en) A nucleic acid delivery vector comprising a circular single stranded polynucleotide
KR102664627B1 (ko) 포스포로티오에이트화 뉴클레오티드를 포함하는 이중 가닥 콘카테머 dna를 사용하는 생체내 rna 또는 단백질 발현
KR20240107373A (ko) C2c9 뉴클레아제 기반의 신규 게놈 편집 시스템 및 이의 응용
US20230122979A1 (en) Methods of sample normalization
JP2024501892A (ja) 新規の核酸誘導型ヌクレアーゼ
US20250059568A1 (en) Class ii, type v crispr systems
US20250084484A1 (en) Methods and compositions for transcriptome analysis
CA3155960C (en) A nucleic acid delivery vector comprising a circular single stranded polynucleotide
WO2024138131A1 (en) Expanding applications of zgtc alphabet in protein expression and gene editing

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200326

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210416

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210416

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220606

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220905

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230309

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230508

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230606

R150 Certificate of patent or registration of utility model

Ref document number: 7292258

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150